Clearance Summary
LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2 received FDA 510(k) clearance under submission number K946048, sponsored by Clinical Controls, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1995-02-10.
- Submission: K946048
- Applicant / Sponsor: Clinical Controls, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5630
- Decision date: 1995-02-10
Classification & Regulation
This clearance is catalogued under FDA product code JZG and 21 CFR 866.5630, within the Immunology review panel as a Class II device.